Literature DB >> 21191026

Structural comparison of HIV-1 envelope spikes with and without the V1/V2 loop.

Guiqing Hu1, Jun Liu, Kenneth A Taylor, Kenneth H Roux.   

Abstract

We have used cryoelectron tomography of vitreous-ice-embedded HIV-1 virions to compare the envelope (Env) spikes of a wild-type strain with those of a mutant strain in which the V1/V2 loop has been deleted. Deletion of V1/V2 results in a spike with far more structural heterogeneity than is observed in the wild type, likely reflecting greatly enhanced gp120 protomer flexibility. A major difference between the two forms is a pronounced loss of mass from the "peak" of the native Env spike. The apparent loss of contact among three gp120 protomers likely accounts for the more open structure, heterogeneity in configuration, and previous observations that broadly neutralizing epitopes and reactive sites on other structural elements are more exposed in such constructs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21191026      PMCID: PMC3067966          DOI: 10.1128/JVI.01612-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  97 in total

1.  The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region.

Authors:  S W Barnett; S Lu; I Srivastava; S Cherpelis; A Gettie; J Blanchard; S Wang; I Mboudjeka; L Leung; Y Lian; A Fong; C Buckner; A Ly; S Hilt; J Ulmer; C T Wild; J R Mascola; L Stamatatos
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  CD4 binding partially locks the bridging sheet in gp120 but leaves the beta2/3 strands flexible.

Authors:  Yongping Pan; Buyong Ma; Ruth Nussinov
Journal:  J Mol Biol       Date:  2005-07-15       Impact factor: 5.469

3.  Soluble mimetics of human immunodeficiency virus type 1 viral spikes produced by replacement of the native trimerization domain with a heterologous trimerization motif: characterization and ligand binding analysis.

Authors:  Marie Pancera; Jacob Lebowitz; Arne Schön; Ping Zhu; Ernesto Freire; Peter D Kwong; Kenneth H Roux; Joseph Sodroski; Richard Wyatt
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines.

Authors:  John R Mascola; Patricia D'Souza; Peter Gilbert; Beatrice H Hahn; Nancy L Haigwood; Lynn Morris; Christos J Petropoulos; Victoria R Polonis; Marcella Sarzotti; David C Montefiori
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner.

Authors:  Cheryl J Saunders; Ruth A McCaffrey; Irina Zharkikh; Zane Kraft; Susan E Malenbaum; Brian Burke; Cecilia Cheng-Mayer; Leonidas Stamatatos
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.

Authors:  Simon Beddows; Norbert Schülke; Marc Kirschner; Kelly Barnes; Michael Franti; Elizabeth Michael; Thomas Ketas; Rogier W Sanders; Paul J Maddon; William C Olson; John P Moore
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.

Authors:  Elena Chertova; Julian W Bess; Bruce J Crise; Raymond C Sowder II; Terra M Schaden; Joanne M Hilburn; James A Hoxie; Raoul E Benveniste; Jeffrey D Lifson; Louis E Henderson; Larry O Arthur
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

8.  Design of a novel peptide inhibitor of HIV fusion that disrupts the internal trimeric coiled-coil of gp41.

Authors:  Carole A Bewley; John M Louis; Rodolfo Ghirlando; G Marius Clore
Journal:  J Biol Chem       Date:  2002-02-21       Impact factor: 5.157

9.  Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin.

Authors:  Xinzhen Yang; Juliette Lee; Erin M Mahony; Peter D Kwong; Richard Wyatt; Joseph Sodroski
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

10.  A replication-competent, neutralization-sensitive variant of simian immunodeficiency virus lacking 100 amino acids of envelope.

Authors:  Welkin E Johnson; Jennifer Morgan; Julie Reitter; Bridget A Puffer; Susan Czajak; Robert W Doms; Ronald C Desrosiers
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

View more
  40 in total

1.  Molecular architecture of the uncleaved HIV-1 envelope glycoprotein trimer.

Authors:  Youdong Mao; Liping Wang; Christopher Gu; Alon Herschhorn; Anik Désormeaux; Andrés Finzi; Shi-Hua Xiang; Joseph G Sodroski
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-11       Impact factor: 11.205

2.  HIV-1 Nef responsiveness is determined by Env variable regions involved in trimer association and correlates with neutralization sensitivity.

Authors:  Yoshiko Usami; Heinrich Göttlinger
Journal:  Cell Rep       Date:  2013-10-24       Impact factor: 9.423

3.  Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer.

Authors:  Qingbo Liu; Priyamvada Acharya; Michael A Dolan; Peng Zhang; Christina Guzzo; Jacky Lu; Alice Kwon; Deepali Gururani; Huiyi Miao; Tatsiana Bylund; Gwo-Yu Chuang; Aliaksandr Druz; Tongqing Zhou; William J Rice; Christoph Wigge; Bridget Carragher; Clinton S Potter; Peter D Kwong; Paolo Lusso
Journal:  Nat Struct Mol Biol       Date:  2017-02-20       Impact factor: 15.369

4.  Tyrosine sulfation in the second variable loop (V2) of HIV-1 gp120 stabilizes V2-V3 interaction and modulates neutralization sensitivity.

Authors:  Raffaello Cimbro; Thomas R Gallant; Michael A Dolan; Christina Guzzo; Peng Zhang; Yin Lin; Huiyi Miao; Donald Van Ryk; James Arthos; Inna Gorshkova; Patrick H Brown; Darrell E Hurt; Paolo Lusso
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

5.  Electron tomography of paracrystalline 2D arrays.

Authors:  Hanspeter Winkler; Shenping Wu; Kenneth A Taylor
Journal:  Methods Mol Biol       Date:  2013

6.  Visualization of retroviral envelope spikes in complex with the V3 loop antibody 447-52D on intact viruses by cryo-electron tomography.

Authors:  Moumita Dutta; Jun Liu; Kenneth H Roux; Kenneth A Taylor
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

7.  The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120.

Authors:  Nicos Karasavvas; Erik Billings; Mangala Rao; Constance Williams; Susan Zolla-Pazner; Robert T Bailer; Richard A Koup; Sirinan Madnote; Duangnapa Arworn; Xiaoying Shen; Georgia D Tomaras; Jeffrey R Currier; Mike Jiang; Craig Magaret; Charla Andrews; Raphael Gottardo; Peter Gilbert; Timothy J Cardozo; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Punnee Pitisuttithum; Jaranit Kaewkungwal; Robert Paris; Kelli Greene; Hongmei Gao; Sanjay Gurunathan; Jim Tartaglia; Faruk Sinangil; Bette T Korber; David C Montefiori; John R Mascola; Merlin L Robb; Barton F Haynes; Viseth Ngauy; Nelson L Michael; Jerome H Kim; Mark S de Souza
Journal:  AIDS Res Hum Retroviruses       Date:  2012-10-04       Impact factor: 2.205

8.  The highly conserved layer-3 component of the HIV-1 gp120 inner domain is critical for CD4-required conformational transitions.

Authors:  Anik Désormeaux; Mathieu Coutu; Halima Medjahed; Beatriz Pacheco; Alon Herschhorn; Christopher Gu; Shi-Hua Xiang; Youdong Mao; Joseph Sodroski; Andrés Finzi
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

Review 9.  Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA.

Authors:  Jean-Philippe Julien; Peter S Lee; Ian A Wilson
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

10.  Inhibition of the HIV-1 spike by single-PG9/16-antibody binding suggests a coordinated-activation model for its three protomeric units.

Authors:  Robin Löving; Mathilda Sjöberg; Shang-Rung Wu; James M Binley; Henrik Garoff
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.